CANTABILINE 400 mg, tablet 30 tablets
Active ingredients: Hymecromone
Commercialized according to BDPM
Tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CANTABILINE 400 mg, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) PVC-aluminium de 30 comprimé(s)
- Marketing authorisation holder
- DB PHARMA
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 19 Jan 1984
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61974317CIP73219213CIP133400932192137Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| HYMÉCROMONEcomprimé | 400 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.